vs
牛津地产（IIPR）与NATURAL ALTERNATIVES INTERNATIONAL INC（NAII）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是NATURAL ALTERNATIVES INTERNATIONAL INC的1.9倍（$66.7M vs $34.8M），牛津地产净利率更高（47.8% vs -7.3%，领先55.1%），NATURAL ALTERNATIVES INTERNATIONAL INC同比增速更快（2.1% vs -13.1%），过去两年NATURAL ALTERNATIVES INTERNATIONAL INC的营收复合增速更高（17.7% vs -6.0%）
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
天然替代品国际公司（NAI）是一家总部位于美国加利福尼亚州卡尔斯巴德的企业，主打营养补充剂生产，知名产品包括Juice Plus。公司由马克·A·勒杜创立于1980年，生产基地分布在美国加利福尼亚州维斯塔、瑞士与日本，在营养补充剂代工生产领域拥有多年经验。
IIPR vs NAII — 直观对比
营收规模更大
IIPR
是对方的1.9倍
$34.8M
营收增速更快
NAII
高出15.2%
-13.1%
净利率更高
IIPR
高出55.1%
-7.3%
两年增速更快
NAII
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $66.7M | $34.8M |
| 净利润 | $31.8M | $-2.6M |
| 毛利率 | — | 7.2% |
| 营业利润率 | 47.8% | -5.3% |
| 净利率 | 47.8% | -7.3% |
| 营收同比 | -13.1% | 2.1% |
| 净利润同比 | -20.4% | -16.5% |
| 每股收益（稀释后） | $1.07 | $-0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIPRNAII
| Q4 25 | $66.7M | $34.8M | ||
| Q3 25 | $64.7M | $37.7M | ||
| Q2 25 | $62.9M | $33.9M | ||
| Q1 25 | $71.7M | $28.8M | ||
| Q4 24 | $76.7M | $34.1M | ||
| Q3 24 | $76.5M | $33.1M | ||
| Q2 24 | $79.8M | $29.5M | ||
| Q1 24 | $75.5M | $25.1M |
净利润IIPRNAII
| Q4 25 | $31.8M | $-2.6M | ||
| Q3 25 | $29.3M | $-291.0K | ||
| Q2 25 | $26.0M | $-7.2M | ||
| Q1 25 | $31.1M | $-2.2M | ||
| Q4 24 | $40.0M | $-2.2M | ||
| Q3 24 | $40.2M | $-2.0M | ||
| Q2 24 | $42.0M | $-1.9M | ||
| Q1 24 | $39.4M | $-1.6M |
毛利率IIPRNAII
| Q4 25 | — | 7.2% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 10.4% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 7.6% |
营业利润率IIPRNAII
| Q4 25 | 47.8% | -5.3% | ||
| Q3 25 | 45.5% | 0.8% | ||
| Q2 25 | 45.9% | -5.7% | ||
| Q1 25 | 47.4% | -7.3% | ||
| Q4 24 | 54.7% | -8.2% | ||
| Q3 24 | 54.8% | -5.5% | ||
| Q2 24 | 53.1% | -8.6% | ||
| Q1 24 | 55.7% | -7.8% |
净利率IIPRNAII
| Q4 25 | 47.8% | -7.3% | ||
| Q3 25 | 45.3% | -0.8% | ||
| Q2 25 | 41.4% | -21.3% | ||
| Q1 25 | 43.3% | -7.6% | ||
| Q4 24 | 52.2% | -6.4% | ||
| Q3 24 | 52.6% | -6.0% | ||
| Q2 24 | 52.6% | -6.4% | ||
| Q1 24 | 52.3% | -6.3% |
每股收益（稀释后）IIPRNAII
| Q4 25 | $1.07 | $-0.42 | ||
| Q3 25 | $0.97 | $-0.05 | ||
| Q2 25 | $0.86 | $-1.21 | ||
| Q1 25 | $1.03 | $-0.37 | ||
| Q4 24 | $1.35 | $-0.37 | ||
| Q3 24 | $1.37 | $-0.33 | ||
| Q2 24 | $1.44 | $-0.32 | ||
| Q1 24 | $1.36 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.6M | $3.8M |
| 总债务越低越好 | $393.7M | — |
| 股东权益账面价值 | $1.8B | $67.0M |
| 总资产 | $2.4B | $153.3M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资IIPRNAII
| Q4 25 | $47.6M | $3.8M | ||
| Q3 25 | $41.9M | $7.7M | ||
| Q2 25 | $104.9M | $12.3M | ||
| Q1 25 | $133.3M | $10.6M | ||
| Q4 24 | $151.2M | $8.7M | ||
| Q3 24 | $172.4M | $10.2M | ||
| Q2 24 | $160.9M | $12.0M | ||
| Q1 24 | $173.5M | $12.4M |
总债务IIPRNAII
| Q4 25 | $393.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IIPRNAII
| Q4 25 | $1.8B | $67.0M | ||
| Q3 25 | $1.9B | $69.0M | ||
| Q2 25 | $1.9B | $68.4M | ||
| Q1 25 | $1.9B | $76.6M | ||
| Q4 24 | $1.9B | $79.1M | ||
| Q3 24 | $1.9B | $80.2M | ||
| Q2 24 | $1.9B | $82.6M | ||
| Q1 24 | $2.0B | $84.1M |
总资产IIPRNAII
| Q4 25 | $2.4B | $153.3M | ||
| Q3 25 | $2.3B | $156.9M | ||
| Q2 25 | $2.3B | $151.9M | ||
| Q1 25 | $2.4B | $154.9M | ||
| Q4 24 | $2.4B | $156.1M | ||
| Q3 24 | $2.4B | $161.3M | ||
| Q2 24 | $2.4B | $162.3M | ||
| Q1 24 | $2.4B | $153.2M |
负债/权益比IIPRNAII
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.2M | $-6.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.3M |
| 自由现金流率自由现金流/营收 | — | -20.9% |
| 资本支出强度资本支出/营收 | — | 2.7% |
| 现金转化率经营现金流/净利润 | 6.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $-5.2M |
8季度趋势，按日历期对齐
经营现金流IIPRNAII
| Q4 25 | $198.2M | $-6.3M | ||
| Q3 25 | $45.6M | $-4.0M | ||
| Q2 25 | $48.4M | $3.3M | ||
| Q1 25 | $54.2M | $6.0M | ||
| Q4 24 | $258.4M | $37.0K | ||
| Q3 24 | $64.9M | $-3.4M | ||
| Q2 24 | $64.2M | $-2.7M | ||
| Q1 24 | $71.6M | $-3.6M |
自由现金流IIPRNAII
| Q4 25 | — | $-7.3M | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $-1.0M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | — | $-3.9M |
自由现金流率IIPRNAII
| Q4 25 | — | -20.9% | ||
| Q3 25 | — | -13.4% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 18.0% | ||
| Q4 24 | — | -3.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -12.7% | ||
| Q1 24 | — | -15.5% |
资本支出强度IIPRNAII
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 1.1% |
现金转化率IIPRNAII
| Q4 25 | 6.22× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 6.46× | — | ||
| Q3 24 | 1.61× | — | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIPR
暂无分部数据
NAII
| Private Label Contract Manufacturing | $32.8M | 94% |
| Patent And Trademark Licensing | $2.0M | 6% |
